These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Accuracy and preference assessment of prefilled insulin pen versus vial and syringe with diabetes patients, caregivers, and healthcare professionals. Pfützner A; Bailey T; Campos C; Kahn D; Ambers E; Niemeyer M; Guerrero G; Klonoff D; Nayberg I Curr Med Res Opin; 2013 May; 29(5):475-81. PubMed ID: 23402225 [TBL] [Abstract][Full Text] [Related]
23. FlexPen: addressing issues of confidence and convenience in insulin delivery. Korytkowski M; Niskanen L; Asakura T Clin Ther; 2005; 27 Suppl B():S89-100. PubMed ID: 16519040 [TBL] [Abstract][Full Text] [Related]
24. Usability of the Gla-300 Injection Device Compared With Three Other Commercialized Disposable Insulin Pens: Results of an Interview-Based Survey. Klonoff D; Nayberg I; Erbstein F; Cali A; Brulle-Wohlhueter C; Haak T J Diabetes Sci Technol; 2015 Jul; 9(4):936-8. PubMed ID: 26002837 [No Abstract] [Full Text] [Related]
25. Comparison of usability and patient preference for the new disposable insulin device Solostar versus Flexpen, lilly disposable pen, and a prototype pen: an open-label study. Haak T; Edelman S; Walter C; Lecointre B; Spollett G Clin Ther; 2007 Apr; 29(4):650-60. PubMed ID: 17617288 [TBL] [Abstract][Full Text] [Related]
26. Preference for insulin delivery systems among current insulin users and nonusers. Summers KH; Szeinbach SL; Lenox SM Clin Ther; 2004 Sep; 26(9):1498-505. PubMed ID: 15531012 [TBL] [Abstract][Full Text] [Related]
27. Dose accuracy comparison between SoloSTAR and FlexPen at three different dose levels. Penfornis A; Horvat K Diabetes Technol Ther; 2008 Oct; 10(5):359-62. PubMed ID: 18715211 [TBL] [Abstract][Full Text] [Related]
29. Adherence to premixed insulin in a prefilled pen compared with a vial/syringe in people with diabetes in Singapore. Cheen HH; Lim SH; Huang MC; Bee YM; Wee HL Clin Ther; 2014 Jul; 36(7):1043-53. PubMed ID: 24913030 [TBL] [Abstract][Full Text] [Related]
30. Usability and preference assessment of a new prefilled insulin pen versus vial and syringe in people with diabetes, physicians and nurses. Campos C; Lajara R; Deluzio T Expert Opin Pharmacother; 2012 Sep; 13(13):1837-46. PubMed ID: 22873943 [TBL] [Abstract][Full Text] [Related]
31. Potential Insulin Underdelivery from Prefilled and Reusable Insulin Pens in Cases of Premature Needle Withdrawal: A Laboratory Evaluation. Joubert M; Haddouche A; Morera J; Rod A; Reznik Y Diabetes Technol Ther; 2015 Oct; 17(10):712-6. PubMed ID: 26355757 [TBL] [Abstract][Full Text] [Related]
32. [Evaluation of a new disposable insulin pen and injection habits of diabetes patients in everyday clinical practice]. Böhler S; Landgraf W; Schreiber SA MMW Fortschr Med; 2010 Jan; 151 Suppl 4():179-87. PubMed ID: 21595146 [TBL] [Abstract][Full Text] [Related]
33. Insulin delivery by injection in children and adolescents with diabetes. Hanas R; de Beaufort C; Hoey H; Anderson B Pediatr Diabetes; 2011 Aug; 12(5):518-26. PubMed ID: 21481121 [TBL] [Abstract][Full Text] [Related]
35. Does pen help? A real-world outcomes study of switching from vial to disposable pen among insulin glargine-treated patients with type 2 diabetes mellitus. Xie L; Zhou S; Wei W; Gill J; Pan C; Baser O Diabetes Technol Ther; 2013 Mar; 15(3):230-6. PubMed ID: 23336845 [TBL] [Abstract][Full Text] [Related]
36. Usage and perceptions of pen injectors for diabetes management: a survey of type 2 diabetes patients in the United States. Toscano D; Brice J; Alfaro C J Diabetes Sci Technol; 2012 May; 6(3):686-94. PubMed ID: 22768901 [TBL] [Abstract][Full Text] [Related]
37. Competency of Prefilled Insulin Pen Usage Among Diabetes Patients in Saudi Arabia: A Cross-sectional Study. Sweidan BA; Al Ajlouni MM; Robert AA; Alzaid AA Curr Diabetes Rev; 2019; 15(3):240-246. PubMed ID: 29804535 [TBL] [Abstract][Full Text] [Related]
38. Usability and preference evaluation of a prefilled insulin pen with a novel injection mechanism by people with diabetes and healthcare professionals. Bailey T; Thurman J; Niemeyer M; Schmeisl G Curr Med Res Opin; 2011 Oct; 27(10):2043-52. PubMed ID: 21916529 [TBL] [Abstract][Full Text] [Related]
39. Analysis and perspective: A randomized, open-label, comparative crossover handling trial between two durable pens in patients with type 1 or 2 diabetes mellitus. Bailey TS J Diabetes Sci Technol; 2011 Sep; 5(5):1222-3. PubMed ID: 22027322 [TBL] [Abstract][Full Text] [Related]